PMID- 141548
OWN - NLM
STAT- MEDLINE
DCOM- 19770825
LR  - 20071115
IS  - 0022-5223 (Print)
IS  - 0022-5223 (Linking)
VI  - 74
IP  - 1
DP  - 1977 Jul
TI  - Long-term survival after tricuspid valve replacement. Results with seven 
      different prostheses.
PG  - 20-7
AB  - The experience with tricuspid valve replacement (TVR) with seven different 
      prostheses, alone or combined with replacement of other valves, in 73 patients 
      (64 rheumatic and nine nonrheumatic) between 1964 and March, 1975, at the 
      University of Alberta Hospital has been reviewed. Early and late mortality rates 
      in rheumatic patients were 41 and 23 percent, respectively (36 percent being 
      alive after a mean of 5.6 years), compared to 33 and 11 percent, respectively, in 
      the nonrheumatic patients (56 percent being alive after a mean of 2 years). Of 
      all survivors, 88 percent were functionally improved. Among the rheumatic 
      patients: (1) 88 percent had organic tricuspid disease; (2) of the 39 patients 
      with tricuspid insufficiency who underwent corrective mitral surgery 7 years 
      before TVR, the tricuspid insufficiency had progressed over the 7 years; (3) the 
      number of patients with tricuspid insufficiency had increased (39 versus 59) over 
      the same 7 year period; (4) a high early mortality rate was encountered in those 
      who were preoperatively in New York Heart Association (N.Y.H.A.) Class IV, or who 
      had cardiomegaly, or pulmonary hypertension, or poor ventricular function, or 
      organic disease, or reoperation; (5) the percentages of survivors with different 
      prostheses were: Starr-Edwards, 31 percent; Beall-Surgitool, 14 percent; 
      Kay-Shiley, 46 percent, Bjork-Shiley, 50 percent; Lillehei-Kaster, 100 percent; 
      Cutter-Smeloff and Wada-Cutter, nil. Among the nonrheumatic patients, two with 
      the Cutter-Smeloff, two with the Beall-Surgitool, and one with the 
      Lillehei-Kaster were alive after 14, 37, and 15 months, respectively. Among all 
      survivors of TVR, late thrombus and pannus developed on both ball and disc 
      prostheses (Starr-Edwards, two; Cutter-Smeloff, one; Lillehei-Kaster, one). These 
      findings suggest that TVR should be performed earlier in rheumatic patients to 
      reduce the operative mortality rate and that the Lillehei-Kaster prosthesis is 
      probably most suitable for TVR.
FAU - Jugdutt, B I
AU  - Jugdutt BI
FAU - Fraser, R S
AU  - Fraser RS
FAU - Lee, S J
AU  - Lee SJ
FAU - Rossall, R E
AU  - Rossall RE
FAU - Callaghan, J C
AU  - Callaghan JC
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - United States
TA  - J Thorac Cardiovasc Surg
JT  - The Journal of thoracic and cardiovascular surgery
JID - 0376343
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Cardiomegaly/complications
MH  - Child
MH  - Ebstein Anomaly/surgery
MH  - Female
MH  - Follow-Up Studies
MH  - Heart Valve Prosthesis/*mortality
MH  - Humans
MH  - Hypertension, Pulmonary/complications
MH  - Male
MH  - Middle Aged
MH  - Mitral Valve Insufficiency/complications
MH  - Postoperative Complications
MH  - Prognosis
MH  - Rheumatic Heart Disease/surgery
MH  - Time Factors
MH  - *Tricuspid Valve
MH  - Tricuspid Valve Insufficiency/complications/surgery
EDAT- 1977/07/01 00:00
MHDA- 1977/07/01 00:01
CRDT- 1977/07/01 00:00
PHST- 1977/07/01 00:00 [pubmed]
PHST- 1977/07/01 00:01 [medline]
PHST- 1977/07/01 00:00 [entrez]
PST - ppublish
SO  - J Thorac Cardiovasc Surg. 1977 Jul;74(1):20-7.